Research credibility depends on clear, consistent disclosure of conflicts of interest so readers, peers, and policymakers can assess potential sources of bias. Contemporary standards from the International Committee of Medical Journal Editors and the Committee on Publication Ethics require authors to report financial and nonfinancial relationships that could influence design, conduct, interpretation, or reporting. Full disclosure does not imply wrongdoing; it enables informed judgment.
What counts as a conflict of interest?
A conflict of interest includes direct financial ties such as grants, consulting fees, stock ownership, patents, and in-kind support, as well as non-financial interests like unpaid advisory roles, strong advocacy positions, or close personal relationships with stakeholders. Research on industry influence by Lisa Bero University of Sydney has documented patterns where industry sponsorship correlates with favorable outcomes in some fields, illustrating why transparent reporting matters. John P.A. Ioannidis Stanford University has highlighted how undisclosed influences can undermine reproducibility and public confidence. Context matters: a disclosed relationship may be perfectly manageable depending on the study design, oversight, and mitigation measures.
Best practices for disclosure
Researchers should disclose relevant relationships early, often, and in accessible places. Best practice is to name the sponsor, describe the sponsor’s role in the work, list monetary amounts or approximate ranges when appropriate, and declare any ownership or equity that could be affected by the results. Many journals and funders adopt the ICMJE disclosure form and commonly ask about relationships within the prior 36 months; institutional conflict-of-interest offices typically maintain management plans when significant risks are identified. Public repositories, clinical trial registries, and manuscript footnotes are complementary venues to ensure disclosures reach diverse audiences. The Committee on Publication Ethics provides guidance on handling undisclosed conflicts when they are discovered after publication. Transparency also includes institutional accountability: universities and funders should publish policies and enforcement records so readers can evaluate governance.
Consequences of inadequate disclosure
Failure to disclose can erode trust in science, skew research agendas toward sponsor priorities, and lead to policy or clinical decisions based on incomplete information. This is especially consequential in areas where research affects communities, land, or ecosystems; for example, resource extraction studies funded by corporate interests can carry territorial and environmental implications for Indigenous peoples and local residents. In low-resource settings the cultural expectation of informal relationships and limited institutional oversight can complicate disclosure, making capacity-building and clear, locally appropriate policies essential. When undisclosed conflicts surface they may prompt corrections, retractions, or loss of public trust, all of which impair the social value of research.
Clear, consistent disclosure coupled with robust management strikes a balance between enabling collaborative research and protecting the integrity of evidence. By following established standards like those from the International Committee of Medical Journal Editors and seeking institutional oversight, researchers and journals preserve the credibility that underpins science and public policy.